Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROOF study of intravenous fosfomycin for prosthetic joint infection
2016-002673-35Phase 4Active
- Sponsor
- Pro-Implant Foundation
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fosfomycin in periprosthetic joint infection (PJI), sponsored by Pro-Implant Foundation. Started Dec 2016; status: active.
02
Drugs
fosfomycin
03
Conditions
periprosthetic joint infection (PJI)
Beyond the preview
Go deeper on 2016-002673-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002673-35.